Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 148039, 7 pages
http://dx.doi.org/10.1155/2012/148039
Review Article

Proteomic Analyses of the Vitreous Humour

1Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
2Department of Ophthalmology, Spedali Civili di Brescia, University of Brescia, Brescia, Italy
3Department of Ophthalmology, Istituto Clinico Humanitas, Milan, Italy

Received 7 July 2012; Accepted 3 August 2012

Academic Editor: Ahmed M. Abu El-Asrar

Copyright © 2012 Martina Angi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. N. Bishop, “Structural macromolecules and supramolecular organisation of the vitreous gel,” Progress in Retinal and Eye Research, vol. 19, no. 3, pp. 323–344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Sebag, “The vitreous,” in Adlers Physiology of the Eye, W. Hart, Ed., pp. 268–347, Mosby St. Louis, 1992. View at Google Scholar
  3. J. N. Ulrich, M. Spannagl, A. Kampik, and A. Gandorfer, “Components of the fibrinolytic system in the vitreous body in patients with vitreoretinal disorders,” Clinical and Experimental Ophthalmology, vol. 36, no. 5, pp. 431–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. P. N. Bishop, M. Takanosu, M. Le Goff, and R. Mayne, “The role of the posterior ciliary body in the biosynthesis of vitreous humour,” Eye, vol. 16, no. 4, pp. 454–460, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. C. W. Wu, J. L. Sauter, P. K. Johnson, C. D. Chen, and T. W. Olsen, “Identification and localization of major soluble vitreous proteins in human ocular tissue,” American Journal of Ophthalmology, vol. 137, no. 4, pp. 655–661, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Shitama, H. Hayashi, S. Noge et al., “Proteome profiling of vitreoretinal diseases by cluster analysis,” Proteomics—Clinical Applications, vol. 2, no. 9, pp. 1265–1280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Cassidy, P. Barry, C. Shaw, J. Duffy, and S. Kennedy, “Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders,” British Journal of Ophthalmology, vol. 82, no. 2, pp. 181–185, 1998. View at Google Scholar · View at Scopus
  8. A. M. Abu El-Asrar, M. I. Nawaz, D. Kangave et al., “Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy,” Acta Diabetologica. In press.
  9. K. Nagata, K. Maruyama, K. Uno et al., “Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis,” Investigative Ophthalmology & Visual Science, vol. 53, no. 7, pp. 3827–3833, 2012. View at Google Scholar
  10. T. Yoshimura, K. H. Sonoda, M. Sugahara et al., “Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases,” PLoS ONE, vol. 4, no. 12, Article ID e8158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Mallick and B. Kuster, “Proteomics: a pragmatic perspective,” Nature Biotechnology, vol. 28, no. 7, pp. 695–709, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. B. B. Gao, A. Clermont, S. Rook et al., “Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation,” Nature Medicine, vol. 13, no. 2, pp. 181–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. B. B. Gao, X. Chen, N. Timothy, L. P. Aiello, and E. P. Feener, “Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy,” Journal of Proteome Research, vol. 7, no. 6, pp. 2516–2525, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. García-Ramírez, F. Canals, C. Hernández et al., “Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy,” Diabetologia, vol. 50, no. 6, pp. 1294–1303, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Kim, S. J. Kim, K. Kim et al., “Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients,” Proteomics, vol. 7, no. 22, pp. 4203–4215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Koyama, T. Nakanishi, T. Ikeda, and A. Shimizu, “Catalogue of soluble proteins in human vitreous humor by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrospray ionization mass spectrometry including seven angiogenesis-regulating factors,” Journal of Chromatography B, vol. 792, no. 1, pp. 5–21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. E. Neal, F. A. Bettelheim, C. Lin, K. C. Winn, D. L. Garland, and J. S. Zigler, “Alterations in human vitreous humour following cataract extraction,” Experimental Eye Research, vol. 80, no. 3, pp. 337–347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Ouchi, K. West, J. W. Crabb, S. Kinoshita, and M. Kamei, “Proteomic analysis of vitreous from diabetic macular edema,” Experimental Eye Research, vol. 81, no. 2, pp. 176–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Simó, M. Higuera, M. García-Ramírez, F. Canals, J. García-Arumí, and C. Hernández, “Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients,” Archives of Ophthalmology, vol. 126, no. 8, pp. 1076–1081, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Wang, L. Feng, J. W. Hu et al., “Characterisation of the vitreous proteome in proliferative diabetic retinopathy,” Proteome Science, vol. 10, no. 1, article 15, 2012. View at Google Scholar
  21. K. Yamane, A. Minamoto, H. Yamashita et al., “Proteome analysis of human vitreous proteins,” Molecular & Cellular Proteomics, vol. 2, no. 11, pp. 1177–1187, 2003. View at Google Scholar · View at Scopus
  22. J. Yu, F. Liu, S. J. Cui et al., “Vitreous proteomic analysis of proliferative vitreoretinopathy,” Proteomics, vol. 8, no. 17, pp. 3667–3678, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Nakanishi, R. Koyama, T. Ikeda, and A. Shimizu, “Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole,” Journal of Chromatography B, vol. 776, no. 1, pp. 89–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. J. Kim, S. Kim, J. Park et al., “Differential expression of vitreous proteins in proliferative diabetic retinopathy,” Current Eye Research, vol. 31, no. 3, pp. 231–240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Domon and R. Aebersold, “Options and considerations when selecting a quantitative proteomics strategy,” Nature Biotechnology, vol. 28, no. 7, pp. 710–721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Skeie and V. B. Mahajan, “Dissection of human vitreous body elements for proteomic analysis,” Journal of Visualized Experiments, no. 47, Article ID 2455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. W. Johnson, “Improvements in the understanding and treatment of macular hole,” Current Opinion in Ophthalmology, vol. 13, no. 3, pp. 152–160, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Mandal, S. Heegaard, J. U. Prause, B. Honoré, and H. Vorum, “Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry,” Biological Procedures Online, vol. 12, no. 1, pp. 56–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Patel, E. Solanki, R. Picciani, V. Cavett, J. A. Caldwell-Busby, and S. K. Bhattacharya, “Strategies to recover proteins from ocular tissues for proteomics,” Proteomics, vol. 8, no. 5, pp. 1055–1070, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Sebag and E. A. Balazs, “Morphology and ultrastructure of human vitreous fibers,” Investigative Ophthalmology and Visual Science, vol. 30, no. 8, pp. 1867–1871, 1989. View at Google Scholar · View at Scopus
  31. U. Garg, R. Althahabi, V. Amirahmadi, M. Brod, C. Blanchard, and T. Young, “Hyaluronidase as a liquefying agent for chemical analysis of vitreous fluid,” Journal of Forensic Sciences, vol. 49, no. 2, pp. 388–391, 2004. View at Google Scholar · View at Scopus
  32. A. R. McNeil, A. Gardner, and S. Stables, “Simple method for improving the precision of electrolyte measurements in vitreous humor,” Clinical Chemistry, vol. 45, no. 1, pp. 135–136, 1999. View at Google Scholar · View at Scopus
  33. T. Liu, W. J. Qian, H. M. Mottaz et al., “Evaluation of multiprotein immunoaffnity subtraction for plasma proteomics and candidate biomaker discovery using mass spectrometry,” Molecular and Cellular Proteomics, vol. 5, no. 11, pp. 2167–2174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Gorg, C. Obermaier, G. Boguth et al., “The current state of two-dimensional electrophoresis with immobilized pH gradients,” Electrophoresis, vol. 21, no. 6, pp. 1037–1053, 2000. View at Google Scholar
  35. T. Rabilloud, “The whereabouts of 2D gels in quantitative proteomics,” Methods in Molecular Biology, vol. 893, pp. 25–35, 2012. View at Google Scholar
  36. N. S. Tannu and S. E. Hemby, “Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling,” Nature Protocols, vol. 1, no. 4, pp. 1732–1742, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Hernández, M. García-Ramírez, N. Colomé et al., “New pathogenic candidates for diabetic macular edema detected by proteomic analysis,” Diabetes Care, vol. 33, no. 7, article e92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Karas and F. Hillenkamp, “Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons,” Analytical Chemistry, vol. 60, no. 20, pp. 2299–2301, 1988. View at Google Scholar · View at Scopus
  39. J. B. Fenn, M. Mann, C. K. Meng, S. F. Wong, and C. M. Whitehouse, “Electrospray ionization for mass spectrometry of large biomolecules,” Science, vol. 246, no. 4926, pp. 64–71, 1989. View at Google Scholar · View at Scopus
  40. R. Aebersold and M. Mann, “Mass spectrometry-based proteomics,” Nature, vol. 422, no. 6928, pp. 198–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. J. S. Cottrell, “Protein identification by peptide mass fingerprinting,” Peptide Research, vol. 7, no. 3, pp. 115–124, 1994. View at Google Scholar · View at Scopus
  42. T. C. Lam, R. K. Chun, K. K. Li, and C. H. To, “Application of proteomic technology in eye research: a mini review,” Clinical and Experimental Optometry, vol. 91, no. 1, pp. 23–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Shen, R. Zhao, S. J. Berger, G. A. Anderson, N. Rodriguez, and R. D. Smith, “High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics,” Analytical Chemistry, vol. 74, no. 16, pp. 4235–4249, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Peng, J. E. Elias, C. C. Thoreen, L. J. Licklider, and S. P. Gygi, “Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome,” Journal of Proteome Research, vol. 2, no. 1, pp. 43–50, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. W. J. Qian, J. M. Jacobs, D. G. Camp et al., “Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry,” Proteomics, vol. 5, no. 2, pp. 572–584, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. A. I. Nesvizhskii, O. Vitek, and R. Aebersold, “Analysis and validation of proteomic data generated by tandem mass spectrometry,” Nature Methods, vol. 4, no. 10, pp. 787–797, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. R. W. Lee and A. D. Dick, “Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation,” Eye, vol. 26, no. 1, pp. 17–28, 2012. View at Google Scholar
  48. M. D. de Smet, S. R. Taylor, B. Bodaghi et al., “Understanding uveitis: the impact of research on visual outcomes,” Progress in Retinal and Eye Research, vol. 30, no. 6, pp. 452–470, 2011. View at Google Scholar
  49. M. D. de Smet and C. C. Chan, “Regulation of ocular inflammation—what experimental and human studies have taught us,” Progress in Retinal and Eye Research, vol. 20, no. 6, pp. 761–797, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. S. C. Bahk, S. H. Lee, J. U. Jang et al., “Identification of crystallin family proteins in vitreous body in rat endotoxin-induced uveitis: involvement of crystallin truncation in uveitis pathogenesis,” Proteomics, vol. 6, no. 11, pp. 3436–3444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. C. A. Deeg, B. Amann, A. J. Raith, and B. Kaspers, “Inter- and intramolecular epitope spreading in equine recurrent uveitis,” Investigative Ophthalmology and Visual Science, vol. 47, no. 2, pp. 652–656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Werry and H. Gerhards, “The surgical therapy of equine recurrent uveitis,” Tierarztliche Praxis, vol. 20, no. 2, pp. 178–186, 1992. View at Google Scholar · View at Scopus
  53. C. A. Deeg, F. Altmann, S. M. Hauck et al., “Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier,” Proteomics, vol. 7, no. 9, pp. 1540–1548, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. S. M. Hauck, F. Hofmaier, J. Dietter et al., “Label-free LC-MSMS analysis of vitreous from autoimmune uveitis reveals a significant decrease in secreted Wnt signalling inhibitors DKK3 and SFRP2,” Journal of Proteomics, vol. 75, no. 14, pp. 4545–4554, 2012. View at Google Scholar